Supriya Lifescience Limited

SUPRIYA

Quarterly results

standalone

Revenue and net profit

₹ crore

Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.

  • Income
  • ₹ crore

    Jun 2026190

    Quarter₹ croreYoY
    Jun 2024161+21.7%
    Sept 2024166+18.6%
    Dec 2024186+32.5%
    Mar 2025184+16.4%
    Jun 2025145-9.7%
    Sept 2025200+20.3%
    Dec 2025206+11.2%
    Mar 2026277+50.2%
    Jun 2026190+30.8%
  • ₹ crore

    Jun 20263

    Quarter₹ crore
    Jun 20242
    Sept 20243
    Dec 20242
    Mar 20253
    Jun 20253
    Sept 20253
    Dec 20253
    Mar 20263
    Jun 20263
  • ₹ crore

    Jun 2026192

    Quarter₹ crore
    Jun 2024163
    Sept 2024169
    Dec 2024188
    Mar 2025187
    Jun 2025148
    Sept 2025203
    Dec 2025209
    Mar 2026280
    Jun 2026192
  • Cost structure
  • ₹ crore

    Jun 202628

    Quarter₹ crore
    Jun 202420
    Sept 202420
    Dec 202420
    Mar 202521
    Jun 202523
    Sept 202524
    Dec 202525
    Mar 202625
    Jun 202628
  • ₹ crore

    Jun 2026152

    Quarter₹ crore
    Jun 2024103
    Sept 2024107
    Dec 2024125
    Mar 2025123
    Jun 2025100
    Sept 2025134
    Dec 2025142
    Mar 2026188
    Jun 2026152
  • Exceptional items and tax
  • ₹ crore

    Jun 202641

    Quarter₹ crore
    Jun 202460
    Sept 202462
    Dec 202463
    Mar 202564
    Jun 202547
    Sept 202568
    Dec 202567
    Mar 202692
    Jun 202641
  • ₹ crore

    Jun 202617

    Quarter₹ crore
    Jun 202415
    Sept 202416
    Dec 202416
    Mar 202514
    Jun 202513
    Sept 202518
    Dec 202517
    Mar 202618
    Jun 202617
  • Profit
  • ₹ crore

    Jun 202624

    Quarter₹ croreYoY
    Jun 202445+56.6%
    Sept 202446+93.2%
    Dec 202447+57.1%
    Mar 202550+36.4%
    Jun 202535-22.1%
    Sept 202550+9.3%
    Dec 202550+6.2%
    Mar 202674+47.3%
    Jun 202624-30.9%
  • Per share
  • ₹ per share

    Jun 20262.99

    Quarter₹ per share
    Jun 20245.54
    Sept 20245.71
    Dec 20245.82
    Mar 20256.29
    Jun 20254.32
    Sept 20256.27
    Dec 20256.17
    Mar 20269.22
    Jun 20262.99
  • Leverage
  • Debt to equity

    times

    Dec 20240.00x

    Quartertimes
    Jun 2024—
    Sept 2024—
    Dec 20240.00x
    Mar 2025—
    Jun 2025—
    Sept 2025—
    Dec 2025—
    Mar 2026—
    Jun 2026—
₹ croreJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Income
161166186184145200206277190
Revenue YoY+21.7%+18.6%+32.5%+16.4%-9.7%+20.3%+11.2%+50.2%+30.8%
232333333
163169188187148203209280192
Cost structure
202020212324252528
103107125123100134142188152
Exceptional items and tax
606263644768679241
151616141318171817
Profit
454647503550507424
Net profit YoY+56.6%+93.2%+57.1%+36.4%-22.1%+9.3%+6.2%+47.3%-30.9%
Per share
5.545.715.826.294.326.276.179.222.99
Leverage
Debt to equity——0.00x——————

Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.

VValue Huddle

Indian company filings, read properly. Ownership, results and pledges.

The data

  • 2,914 companies
  • Screener built 16 Nov 2026
  • No share prices, by design

Figures may contain errors of transcription or of the filing itself. Nothing here is investment advice, a recommendation, or a share price. Companies revise their filings; where we hold a revision, the revised figure is the one shown.